FDA Cites Benefits of Merck HIV Drug
September 1, 2007 By MATTHEW PERRONE, AP Business Writer(AP) -- A new HIV-fighting drug from Merck & Co. appears superior to options for patients who have stopped responding to available drugs, federal regulators said Friday.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
FDA sees no safety issues with Pfizer HIV drug
Oct 06, 2009 |
not rated yet |
0
FDA finds bits of steel, rubber in Genzyme drugs
Nov 13, 2009 |
5 / 5 (2) |
0
FDA approves antiretroviral drug
Aug 07, 2007 |
5 / 5 (1) |
0
FDA notes heart events, tumors with Novo drug
Mar 31, 2009 |
not rated yet |
0
WHO: Treat HIV patients sooner
Nov 30, 2009 |
not rated yet |
0
